InCarda Therapeutics, Inc. — Form D
InCarda Therapeutics, Inc. of NEWARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-10-21. The offering totals $50.0M, of which $28.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-10-21
- Form: D
- Accession: 0001567619-20-018042
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $50.0M
- Amount sold: $28.0M
- Remaining: $22.0M
- Investors: 5
- Date of first sale: 2020-10-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-378475
Issuer
- Name: InCarda Therapeutics, Inc.
- CIK: 0001552622
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 39899 BALENTINE DRIVE, SUITE 185, NEWARK, CA, 94560
- Phone: 408-219-2576
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Isaac Cheng | Director | Portland, ME |
| Johan Christenson | Director | NEWARK, CA |
| Grace Colon | Director | NEWARK, CA |
| Alan Colowick | Director | Belmont, CA |
| Andrew ElBardissi | Director | St. Louis Park, MN |
| Dan Welch | Director | NEWARK, CA |
| Grace Colon | Executive Officer | NEWARK, CA |
| John S Patton | Director | Durham, NC |
| John S Patton | Executive Officer | Durham, NC |
| Bischofberger Norbert | Director | Newark, CA |
| Rangachari Narasimhan | Director | Brisbane, CA |
| Rangachari Narasimhan | Executive Officer | Brisbane, CA |
| McCarthy Reenie | Director | Brisbane, CA |
| Miller Samantha | Executive Officer | Brisbane, CA |
| Grace S Colon | Director | San Francisco, CA |
| Grace S Colon | Executive Officer | San Francisco, CA |
| Carlos A Schuler | Director | San Francisco, CA |
| Carlos A Schuler | Executive Officer | San Francisco, CA |
Other filings by this issuer (5)
More